Vonend Oliver, Turner Clare M, Chan Choong M, Loesch Andrew, Dell'Anna G Carmen, Srai Kaila S, Burnstock Geoffrey, Unwin Robert J
Centre for Nephrology and Department of Physiology, Royal Free and University College Medical School, University College London, London, United Kingdom.
Kidney Int. 2004 Jul;66(1):157-66. doi: 10.1111/j.1523-1755.2004.00717.x.
The molecular identification and characterization of the adenosine triphosphate (ATP)-sensitive family of P2 receptors is comparatively new. There are two main subgroups, each with several subtypes and widespread tissue distribution, including the kidney. A unique member of the P2X subgroup of P2 receptors is the ATP-gated ion channel P2X(7), which on activation can cause cell blebbing, cytokine release, and cell death by necrosis or apoptosis. We report expression of this receptor in normal rat kidney and in two chronic models of glomerular injury: streptozotocin-induced (STZ) diabetes and ren-2 transgenic (TGR) hypertension.
At different time points in these models, we used a polyclonal antibody to the P2X(7) receptor and immunohistochemistry to determine its expression and distribution. We also used Western blotting and real-time polymerase chain reaction (PCR) to detect changes in P2X(7) receptor protein and mRNA expression, respectively.
We found only low-level glomerular immuno-staining for the P2X(7) receptor in normal rat kidney, but intense P2X(7) receptor immunostaining of glomeruli in kidneys from diabetic animals at 6 and 9 weeks, and in hypertensive animals at 12 weeks. In diabetic animals, real-time PCR demonstrated a approximately tenfold increase in glomerular P2X(7) receptor mRNA relative to control, and Western blotting confirmed an increase in protein. Immunohistochemistry and immunoelectron microscopy showed staining of glomerular podocytes, which was both intracellular and at the plasma membrane.
We conclude that the P2X(7) receptor is not expressed appreciably under normal conditions, but that following glomerular injury it is significantly up-regulated, mainly in podocytes, though also in endothelial and mesangial cells, of animals with STZ-induced diabetes mellitus or TGR hypertension. Although the exact function and regulation of this receptor remain unclear, its association with inflammatory cytokine release and cell death suggests that increased expression might be involved in the pathogenesis of glomerular cell injury or repair.
三磷酸腺苷(ATP)敏感性P2受体家族的分子鉴定和特性研究相对较新。它有两个主要亚组,每个亚组有几个亚型,并且在包括肾脏在内的多种组织中广泛分布。P2受体P2X亚组中的一个独特成员是ATP门控离子通道P2X(7),其激活后可导致细胞肿胀、细胞因子释放以及通过坏死或凋亡引起细胞死亡。我们报告了该受体在正常大鼠肾脏以及两种肾小球损伤慢性模型中的表达情况:链脲佐菌素诱导的(STZ)糖尿病和ren-2转基因(TGR)高血压。
在这些模型的不同时间点,我们使用针对P2X(7)受体的多克隆抗体和免疫组织化学方法来确定其表达和分布。我们还使用蛋白质印迹法和实时聚合酶链反应(PCR)分别检测P2X(7)受体蛋白和mRNA表达的变化。
我们发现正常大鼠肾脏中P2X(7)受体仅存在低水平的肾小球免疫染色,但在糖尿病动物6周和9周时以及高血压动物12周时的肾脏肾小球中,P2X(7)受体免疫染色强烈。在糖尿病动物中,实时PCR显示肾小球P2X(7)受体mRNA相对于对照增加了约10倍,蛋白质印迹法证实了蛋白质的增加。免疫组织化学和免疫电子显微镜显示肾小球足细胞有染色,染色既存在于细胞内也存在于质膜上。
我们得出结论,P2X(7)受体在正常条件下表达不明显,但在肾小球损伤后会显著上调,主要在足细胞中,在内皮细胞和系膜细胞中也有上调,见于STZ诱导的糖尿病或TGR高血压动物。尽管该受体的确切功能和调节机制仍不清楚,但其与炎症细胞因子释放和细胞死亡的关联表明,其表达增加可能参与了肾小球细胞损伤或修复的发病机制。